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Recommendations in this document for actions by public health authorities apply primarily to US
jurisdictions that are not experiencing sustained community transmission. CDC will provide separate
guidance for US jurisdictions with sustained community transmission.
CDC has provided separate guidance for healthcare settings.
Summary of changes
Revisions were made on March 7, 2020, to reflect the following:
Defintions for congregate settings and social distancing were revised
Revisions were made on March 5, 2020, to reflect the following:
Clarified that in jurisdictions without sustained community transmission, decisions for public health action should
be based priorities of public health authorities (e.g., surveillance, contact tracing)., In jurisdictions with sustained
community transmission, travelers and other potentially exposed individuals should follow local guidance. Also
provided a rationale for these changes.
Updated definitions for self-observation, self-monitoring, and self-monitoring with public health supervision
Provided exposure risk definitions and recommended management for countries other than China
Updated recommendations for Crews on Passenger or Cargo Flights
Removed Workplace section
Added links to information on discontinuation of isolation for patients with laboratory-confirmed COVID-19
Clarified that a potentially exposed person’s risk level does not change if symptoms develop
Reorganized tables
Background
CDC is closely monitoring an epidemic of respiratory illness (COVID-19) caused by a novel (new) coronavirus (SARS-CoV-2)
that was first detected in Wuhan, Hubei Province, China.  Chinese health officials have reported tens of thousands of
illnesses with COVID-19 in China and the virus is spreading from person-to-person in many parts of that country. Cases of
COVID-19 are also being reported in a growing number of international locations, several of which are experiencing
sustained community-level or widespread person-to-person transmission. Cases of COVID-19 without direct links to travel
have been reported in the United States and sustained transmission is occurring in some US communities.
Purpose
The purpose of this interim guidance to provide public health authorities and other partners in US jurisdictions that are
not experiencing sustained community transmission of COVID-19 with a framework for assessing and managing risk of
potential exposures to SARS-CoV-2 and implementing public health actions based on a person’s risk level and clinical
presentation. Public health actions may include monitoring or the application of movement restrictions, including
isolation and quarantine, when needed to delay the introduction and spread of SARS-CoV-2 in these communities.
The recommendations in this guidance apply to US-bound travelers who may have been exposed to SARS-CoV-2 and
people identified through contact investigations of laboratory-confirmed cases. CDC acknowledges that state and local
jurisdictions may make risk management decisions that differ from those recommended here. Public health
management decisions should be based on the situation in the jurisdiction and the priorities of public health authorities.
The guidance will be updated based on the evolving circumstances of the epidemic.
Rationale
The guidance was designed for a “containment” approach in the absence of sustained SARS-CoV-2 transmission in US
communities in order to delay introduction and spread of SARS-CoV-2. It focuses on decreasing the risk of unrecognized
case importation from international locations with sustained transmission and managing contacts of laboratory-
confirmed cases. In US jurisdictions that are not experiencing sustained community transmission, these activities are still
important; however, a resource-intense containment approach that focuses on international travelers poses a risk of
diverting public health resources from other priority activities, including surveillance and case finding, contact tracing,
and preparing for community mitigation measures. Allowing health departments the flexibility to prioritize public health
actions in their jurisdictions enables prudent deployment of public health resources where they can have the most
benefit based on the local situation. State and local health departments are best positioned to make such decisions
within their jurisdictions.
In US jurisdictions with sustained community transmission, shifting from containment to mitigation conserves public
health resources and directs them to where they can have the most benefit. In such jurisdictions, residents may have the
same exposure risk as international travelers from countries with sustained transmission; therefore, applying stringent
containment measures to international travelers (e.g., staying home for 14 days) no longer has a public health benefit
and would be arbitrary in the context of similar risk among others in the community.  Applying such containment
measures (e.g., asking people to stay home) community-wide would have severe detrimental effects on community
infrastructure. When SARS-CoV-2 is spreading in a community, it is also not feasible to identify all people with symptoms
compatible with COVID-19 or identify all potentially exposed contacts. Applying stringent containment measures to
people who are tested and have laboratory confirmation and their contacts, but not to others who are not tested and
their contacts, would have no public health benefit. Such an approach could hamper surveillance efforts and ability of
public health authorities to make data-driven decisions for the implementation of community mitigation measures.
Separate CDC guidance is in development that harmonizes recommendations for people who are tested and confirmed
positive for COVID-19 and others in the community who are symptomatic but not tested, as well as their contacts.
Definitions Used in this Guidance
Symptoms compatible with COVID-19, for the purpose of these recommendations, include subjective or measured
fever, cough, or difficulty breathing.
Self-observation means people should remain alert for subjective fever, cough, or difficulty breathing. If they feel
feverish or develop cough or difficulty breathing during the self-observation period, they should take their temperature,
self-isolate, limit contact with others, and seek advice by telephone from a healthcare provider or their local health
department to determine whether medical evaluation is needed.
Self-monitoring means people should monitor themselves for fever by taking their temperatures twice a day and
remain alert for cough or difficulty breathing. If they feel feverish or develop measured fever, cough, or difficulty
breathing during the self-monitoring period, they should self-isolate, limit contact with others, and seek advice by
telephone from a healthcare provider or their local health department to determine whether medical evaluation is
needed.
Self-monitoring with delegated supervision means, for certain occupational groups (e.g., some healthcare or
laboratory personnel, airline crew members), self-monitoring with oversight by the appropriate occupational health or
infection control program in coordination with the health department of jurisdiction. The occupational health or infection
control personnel for the employing organization should establish points of contact between the organization, the self-
monitoring personnel, and the local or state health departments with jurisdiction for the location where personnel will be
during the self-monitoring period. This communication should result in agreement on a plan for medical evaluation of
personnel who develop fever, cough, or difficulty breathing during the self-monitoring period. The plan should include
instructions for notifying occupational health and the local public health authority, and transportation arrangements to a
pre-designated hospital, if medically necessary, with advance notice if fever, cough, or difficulty breathing occur. The
supervising organization should remain in contact with personnel through the self-monitoring period to oversee self-
monitoring activities.
Self-monitoring with public health supervision means public health authorities assume the responsibility for
oversight of self-monitoring for certain groups of people. The ability of jurisdictions to initiate or provide continued
oversight will depend on other competing priorities (e.g., contact tracing, implementation of community mitigation
strategies). Depending on local priorities, CDC recommends that health departments consider establishing initial
communication with these people, provide a plan for self-monitoring and clear instructions for notifying the health
department before the person seeks health care if they develop fever, cough, or difficulty breathing. As resources allow,
health authorities may also check in intermittently with these people over the course of the self-monitoring period. If
travelers for whom public health supervision is recommended are identified at a US port of entry, CDC will notify state
and territorial health departments with jurisdiction for the travelers’ final destinations.
Active monitoring means that the state or local public health authority assumes responsibility for establishing regular
communication with potentially exposed people to assess for the presence of fever, cough, or difficulty breathing. For
people with high-risk exposures, CDC recommends this communication occurs at least once each day. The mode of
communication can be determined by the state or local public health authority and may include telephone calls or any
electronic or internet-based means of communication.
Close contact is defined as:
a) being within approximately 6 feet (2 meters) of a COVID-19 case for a prolonged period of time; close contact can occur
while caring for, living with, visiting, or sharing a healthcare waiting area or room with a COVID-19 case
– or –
b) having direct contact with infectious secretions of a COVID-19 case (e.g., being coughed on)
Public health orders are legally enforceable directives issued under the authority of a relevant federal, state, or local
entity that, when applied to a person or group, may place restrictions on the activities undertaken by that person or
group, potentially including movement restrictions or a requirement for monitoring by a public health authority, for the
purposes of protecting the public’s health. Federal, state, or local public health orders may be issued to enforce isolation,
quarantine or conditional release. The list of quarantinable communicable diseases for which federal public health orders
are authorized is defined by Executive Order and includes “severe acute respiratory syndromes.” COVID-19 meets the
definition for “severe acute respiratory syndromes” as set forth in Executive Order 13295, as amended by Executive Order
13375 and 13674, and, therefore, is a federally quarantinable communicable disease.
Isolation means the separation of a person or group of people known or reasonably believed to be infected with
a communicable disease and potentially infectious from those who are not infected to prevent spread of the
communicable disease. Isolation for public health purposes may be voluntary or compelled by federal, state, or local
public health order.
Quarantine in general means the separation of a person or group of people reasonably believed to have been exposed
to a communicable disease but not yet symptomatic, from others who have not been so exposed, to prevent the possible
spread of the communicable disease.
Conditional release defines a set of legally enforceable conditions under which a person may be released from more
stringent public health movement restrictions, such as quarantine in a secure facility. These conditions may include
public health supervision through in-person visits by a health official or designee, telephone, or any electronic or internet-
based means of communication as determined by the CDC Director or state or local health authority. A conditional
release order may also place limits on travel or require restriction of a person’s movement outside their home.
Controlled travel involves exclusion from long-distance commercial conveyances (e.g., aircraft, ship, train, bus). For
people subject to active monitoring, any long-distance travel should be coordinated with public health authorities to
ensure uninterrupted monitoring. Air travel is not allowed by commercial flight but may occur via approved
noncommercial air transport. CDC may use public health orders or federal public health travel restrictions to enforce
controlled travel. CDC also has the authority to issue travel permits to define the conditions of interstate travel within the
United States for people under certain public health orders or if other conditions are met.
Congregate settings are crowded public places where close contact with others may occur, such as shopping centers,
movie theaters, stadiums.
Social distancing means remaining out of congregate settings, avoiding mass gatherings, and maintaining distance
(approximately 6 feet or 2 meters) from others when possible.
Exposure Risk Categories
These categories are interim and subject to change.
CDC has established the following exposure risk categories to help guide public health management of people following
potential SARS-CoV-2 exposure in jurisdictions that are not experiencing sustained community transmission. These
categories may not cover all potential exposure scenarios. They should not replace an individual assessment of risk for
the purpose of clinical decision making or individualized public health management.
All exposures apply to the 14 days prior to assessment.
For country-level risk classifications, see Coronavirus Disease 2019 Information for Travel.
CDC has provided separate guidance for healthcare settings.
Table 1. Risk Categories for Exposures Associated with International Travel or Identified during Contact
Investigations of Laboratory-confirmed Cases
Risk Level
Geographic (Travel-
associated)
Exposures
Exposures Identified through Contact Investigation
High Travel from Hubei
Province, China
Living in the same household as, being an intimate partner of, or
providing care in a nonhealthcare setting (such as a home) for a person
*
with symptomatic laboratory-confirmed COVID-19 infection without
using recommended precautions for home care and home isolation
Medium
(assumes no
exposures in
the high-risk
category)
Travel from
mainland China
outside Hubei
Province or Iran
Travel from a
country with
widespread
sustained
transmission,
other than China
or Iran
Travel from a
country with
sustained
community
transmission
Close contact with a person with symptomatic laboratory-confirmed
COVID-19
On an aircraft, being seated within 6 feet (two meters) of a traveler
with symptomatic laboratory-confirmed COVID-19 infection; this
distance correlates approximately with 2 seats in each direction
Living in the same household as, an intimate partner of, or caring for
a person in a nonhealthcare setting (such as a home) to a person
with symptomatic laboratory-confirmed COVID-19 infection while
consistently using recommended precautions for home care
and home isolation
Low
(assumes no
exposures in
the high-risk
category)
 Travel from any
other country
Being in the same indoor environment (e.g., a classroom, a hospital
waiting room) as a person with symptomatic laboratory-confirmed COVID-
19 for a prolonged period of time but not meeting the definition of close
contact
No
identifiable
risk
Not applicable Interactions with a person with symptomatic laboratory-confirmed COVID-
19 infection that do not meet any of the high-, medium- or low-risk
conditions above, such as walking by the person or being briefly in the
same room.
In general, geographic exposure categories do not apply to travelers who only transit through an airport.*
Recommendations for Exposure Risk Management
State and local authorities have primary jurisdiction for isolation and other public health orders within their respective
jurisdictions. Federal public health authority primarily extends to international arrivals at ports of entry and to preventing
interstate communicable disease threats.
CDC recognizes that decisions and criteria to use such public health measures may differ by jurisdiction. Consistent with
principles of federalism, state and local jurisdictions may choose to make decisions about isolation, other public health
orders, and monitoring that exceed those recommended in federal guidance. As the domestic COVID-19 situation
evolves, public health authorities should base their decisions about application of individual-level monitoring or
movement restrictions on the situation in their jurisdictions, including whether sustained community transmission is
occurring and competing priorities.
The issuance of public health orders should be considered in the context of other less restrictive means that could
accomplish the same public health goals. People under public health orders must be treated with respect, fairness, and
compassion, and public health authorities should take steps to reduce the potential for stigma (e.g., through outreach to
affected communities, public education campaigns). Considerable, thoughtful planning by public health authorities is
needed to implement public health orders properly.  Specifically, measures must be in place to provide shelter, food,
water, and other necessities for people whose movement is restricted under public health orders, and to protect their
dignity and privacy.
CDC’s recommendations for public health management of international travelers with potential exposure to SARS-CoV-2
and people identified through contact investigations of laboratory-confirmed cases, including monitoring and the
application of travel or movement restrictions, are summarized in Table 2.
Additional recommendations in specific groups or settings are provided below.
Crews on Passenger or Cargo Flights
For country-level risk classifications, see Coronavirus Disease 2019 Information for Travel.  Regardless of residence or
travel history, crew members who have known exposure to persons with COVID-19 should be assessed and managed on
a case-by-case basis.
Air carriers have the authority to adopt occupational health policies for their own employees that exceed CDC’s
recommendations.
US-based crews who have layovers in countries with sustained (community or
widespread) transmission or other international locations
US-based crew members who are on layovers in countries with sustained (community or widespread) transmission
should limit their activities in public and their interactions with local populations and practice social distancing while in
those countries. Crew members who follow these recommendations, and who have no known exposure to persons with
COVID-19, are assessed as low risk. These crew members should self-monitor for 14 days after their layovers under the
supervision of the air carrier’s occupational health program. These crew members have no movement restrictions while
in the United States and may continue to work on passenger or cargo flights as long as they remain asymptomatic. Air
carriers should coordinate with health departments of jurisdiction for crew members’ residences to establish plans for
managing crew members identified as symptomatic. If individualized planning with health departments is infeasible
based on volume of crew members or priorities of health departments, air carriers should at a minimum ensure crew
members know how to contact their local health departments. If they develop fever, cough, or difficulty breathing, crew
members should self-isolate and be excluded from work on flights immediately until cleared by public health authorities.
At this time, CDC recommends that US-based flight crews consider practicing social distancing during layovers or other
travel at all international destinations and self-observation at all times.
Crews based in countries without sustained (community or widespread)
transmission who have had layovers in countries with sustained (community or
widespread) transmission
Crew members who are based in other countries not known to have sustained transmission and who practice social
distancing during layovers in a country with sustained transmission in the past 14 days are assessed as low risk. The crew
members should self-monitor for 14 days after their layovers under the supervision of the air carrier’s occupational
health program while on layovers in the United States. These crew members have no movement restrictions while in the
United States and may continue to work on passenger or cargo flights as long as they remain asymptomatic. Air carriers
should coordinate with health departments of jurisdiction for airports where they operate to establish plans for
managing crew members identified as symptomatic while in the United States. If they develop fever, cough, or difficulty
breathing, crew members should self-isolate and be excluded from work on commercial flights immediately until cleared
by public health authorities.
Crews based in countries with sustained community transmission
Crew members who are based in countries with sustained community transmission and who are in the United States for
layovers are assessed as medium risk but may continue to work on passenger or cargo flights to and within the United
States as long as they remain asymptomatic. The crew members should self-monitor under the supervision of the air
carrier’s occupational health program. These crew members are also recommended practice social distancing while in the
United States. Air carriers should coordinate with health departments of jurisdiction for airports where they operate to
establish plans for managing crew members identified as symptomatic while in the United States. If they develop fever,
cough, or difficulty breathing, crew members should self-isolate and be excluded from work on commercial flights
immediately until cleared by public health authorities.
Crews based in countries with widespread sustained transmission
Crew members who are based in countries with widespread sustained transmission and who are in the United States for
layovers are assessed as medium risk but may continue to work on passenger or cargo flights to and within the United
States as long as they remain asymptomatic. These crew members should self-monitor under the supervision of the air
carrier’s occupational health program. These crew members are also recommended to remain in their hotel rooms, limit
activities in public, and practice social distancing while in the United States. Air carriers should coordinate with health
departments of jurisdiction for airports where they operate to establish plans for managing crew members identified as
symptomatic while in the United States. If they develop fever, cough, or difficulty breathing, crew members should self-
isolate and be excluded from work on commercial flights immediately until cleared by public health authorities.
People with Laboratory-Confirmed COVID-19 and Symptomatic
People Under Investigation for COVID-19
CDC has established criteria for determining when an individual can be considered non-infectious to guide
discontinuation of transmission-based precautions for hospitalized patients or home isolation. While individuals are
considered infectious, local or long-distance travel should occur only by medical transport (e.g., ambulance or air medical
transport) or private vehicle. Isolation and travel restrictions are removed upon determination by public health
authorities that the person is no longer considered to be infectious.
Symptomatic people who meet CDC’s definition of Persons Under Investigation (PUI) should be evaluated by healthcare
providers in conjunction with local health authorities.  PUIs awaiting results of rRT-PCR testing for COVID-19 should
remain in isolation at home or in a healthcare facility until their test results are known.  Depending on the clinical
suspicion of COVID-19, PUIs for whom an initial rRT-PCR test is negative may be candidates for removal of any isolation
and travel restrictions specific to symptomatic people, but any restrictions for asymptomatic people according to the
assigned risk level should still apply.  Management decisions of PUIs who are not tested should be made on a case-by-
case basis, using available epidemiologic and clinical information, in conjunction with CDC guidance.
Contacts of Asymptomatic People Exposed to COVID-19
CDC does not recommend testing, symptom monitoring or special management for people exposed to asymptomatic
people with potential exposures to SARS-CoV-2 (such as in a household), i.e., “contacts of contacts;” these people are not
considered exposed to SARS-CoV-2.
Table 2. Summary of CDC Recommendations for Management of Exposed Persons with by Risk Level and
Presence of Symptoms
The public health actions recommended in the table below apply to people who have been determined to have at least
some risk for COVID-19. People who are being managed as asymptomatic in a particular risk level who develop signs or
symptoms compatible with COVID-19 should be moved immediately into the symptomatic category in the same risk level
and be managed accordingly. The risk level does not change if symptoms develop.
Risk Level Management if Asymptomatic Management if Symptomatic
High risk Quarantine (voluntary or under
public health orders) in a
location to be determined by
public health authorities.
No public activities.
Daily active monitoring, if
possible based on local priorities
Controlled travel
Immediate isolation with consideration of public
health orders
Public health assessment to determine the need for
medical evaluation; if medical evaluation warranted,
diagnostic testing should be guided by CDC’s PUI
definition
If medical evaluation is needed, it should occur with
pre-notification to the receiving HCF and EMS, if EMS
transport indicated, and with all recommended
infection control precautions in place.
Controlled travel: Air travel only via air medical
transport. Local travel is only allowed by medical
transport (e.g., ambulance) or private vehicle while
symptomatic person is wearing a face mask.
Medium risk Close contacts in this category:
Recommendation to remain at
home or in a comparable setting
Practice social distancing
Active monitoring as determined
by local priorities
Recommendation to postpone
long-distance travel on
commercial conveyances
Self-isolation
Public health assessment to determine the need for
medical evaluation; if medical evaluation warranted,
diagnostic testing should be guided by CDC’s PUI
definition
If medical evaluation is needed, it should ideally
occur with pre-notification to the receiving HCF and
EMS, if EMS transport indicated, and with all
recommended infection control precautions in place.
Controlled travel: Air travel only via air medical
transport. Local travel is only allowed by medical
transport (e.g., ambulance) or private vehicle while
symptomatic person is wearing a face mask.
Travelers from mainland China
(outside Hubei Province) or Iran
Recommendation to remain at
home or in a comparable setting
Practice social distancing
Self-monitoring with public
1
health supervision as
determined by local priorities
Recommendation to postpone
additional long-distance travel
on commercial conveyances
after they reach their final
destination
Travelers from other country
with widespread transmission
Recommendation to remain at
home or in a comparable
setting,
Practice social distancing
Self-monitoring
Recommendation to postpone
additional long-distance travel
on commercial conveyances
after they reach their final
destination
Travelers from country with
sustained community
transmission
Practice social distancing
Self-observation
Low risk  No restriction on movement
Self-observation
Self-isolation, social distancing
Person should seek health advice to determine if
medical evaluation is needed.
If sought, medical evaluation and care should be
guided by clinical presentation; diagnostic testing for
COVID-19 should be guided by CDC’s PUI definition
Travel on commercial conveyances should be
postponed until no longer symptomatic.
No identifiable
risk
None Self-isolation, social distancing
Person should seek health advice to determine if
medical evaluation is needed.
If sought, medical evaluation and care should be
guided by clinical presentation; diagnostic testing for
COVID-19 should be guided by CDC’s PUI definition
Travel on commercial conveyances should be
postponed until no longer symptomatic.
EMS = emergency medical services; HCF = healthcare facility; PUI = Person Under Investigation for COVID-19
For the purpose of this document: subjective or measured fever, cough, or difficulty breathing.
Note: The public health management recommendations made above are primarily intended for jurisdictions
not experiencing sustained community transmission. In jurisdictions not experiencing sustained community
transmission, CDC recommends that post-exposure public health management for asymptomatic exposed individuals
continue until 14 days after the last potential exposure; however, these decisions should be made based on the local
situation, available resources, and competing priorities. These factors should also guide decisions about managing
symptomatic exposed individuals.
International travelers and other potentially exposed individuals in jurisdictions experiencing sustained community
transmission should follow local guidance.
For country-level risk classifications, see Coronavirus Disease 2019 Information for Travel.
CDC has provided separate guidance for healthcare settings.
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